LeMaitre Vascular is a global provider of innovative devices for the treatment of peripheral vascular disease. The company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LMAT’s diversified product portfolio … Continue reading →

Derma Sciences, a specialty medical device/pharmaceutical company, manufactures, markets and supplies a complete line of products for wound and skin care. The company has full lines of products in the following categories: Advanced Wound Care, Traditional Wound Care, Burn Care, … Continue reading →

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. ONTY is currently developing multiple therapeutic candidates designed to target cancer in specific and effective ways. The company’s pipeline includes both synthetic … Continue reading →

Top Image Systems is a global provider in the Enterprise Content Management (ECM) solutions market. TISA’s solutions are designed to streamline its customers’ processes and increase efficiencies, providing them with the technology to best meet their specific industry and business … Continue reading →

Tonix Pharmaceuticals Holding is focused on the development of innovative prescription medicines for challenging disorders of the central nervous system, targeting conditions characterized by significant unmet medical need, inadequate existing treatments and high patient and physician dissatisfaction. The company’s core … Continue reading →

Geron is a biopharmaceutical company developing first-in-class therapies for cancer. The company has two lead product candidates in clinical development: imetelstat, which is being evaluated in four phase 2 clinical trials for metastatic breast cancer, advanced non-small cell lung cancer, … Continue reading →

AcelRx Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. ACRX’ lead product candidate, the ARX-01 Sufentanil NanoTab PCA System, is currently in phase 3 clinical … Continue reading →

Onyx Pharmaceuticals is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company’s clinical pipeline includes Nexavar® for treatment of liver, kidney, thyroid and breast cancer; Kyprolis™ … Continue reading →